SEC Form 4 · accession 0001493152-18-003057
Rennova Health, Inc. · RNVA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Mar 6, 2018
Accepted (ET)
Mar 8, 2018 · 11:46 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000931059
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 6, 2018 | A | 26,666,667 | $0.00 | A | 26,666,765 | D | |
| Restricted Stock | holding | — | — | — | 13,333 | D | ||
| Common Stock | holding | — | — | — | 4,282 | I | By: Alcimede LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares granted by Rennova Health, Inc. (the "Company") in connection with the reporting person's services as an officer and director of the Company.
Remarks
Exhibit List - Exhibit 99 - Joint Filer Information